Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation (Q43935803)
Jump to navigation
Jump to search
scientific article published in January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation |
scientific article published in January 2002 |
Statements
1 reference
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation (English)
1 reference
Matthew Arquette
1 reference
Todd Wasserman
1 reference
Ramaswamy Govindan
1 reference
David Garfield
1 reference
Neil Senzer
1 reference
Heidi Gillenwater
1 reference
Mark Socinski
1 reference
1 January 2002
1 reference
1 reference
Identifiers
1 reference